Fatal hepatitis B virus reactivation in a chronic myeloid leukemia patient during imatinib mesylate treatment
Kazuhiko Ikeda(Fukushima Medical University), Yukio Maruyama(Jikei University School of Medicine), Hiromasa Ohira(Fukushima Medical University), Yutaka Shiga, Kaoru Ogawa(Kyoto University), Atsushi Takahashi(Fukushima Medical University), Yuki Sato(Fukushima Medical University), Akiko Nakamura(Aichi Medical University Hospital), T. Kai, Hideyoshi Noji(Fukushima Medical University), K Takeyama(Fukushima Medical University), Hiroshi Kimura(Nagoya University)
Cited by 92
Related Papers
Genome-wide Association Study Identifies TNFSF15 and POU2AF1 as Susceptibility Loci for Primary Biliary Cirrhosis in the Japanese Population
|The American Journal of Human Genetics|2012|272
Human protein factory for converting the transcriptome into an in vitro–expressed proteome
|Nature Methods|2008|269
The efficacy of ursodeoxycholic acid and bezafibrate combination therapy for primary biliary cirrhosis: A prospective, multicenter study
|Hepatology Research|2008|143
Endoscopic ultrasound-guided fine-needle aspiration of solid pancreatic masses with rapid on-site cytological evaluation by endosonographers without attendance of cytopathologists
|Journal of Gastroenterology|2009|132
Association Between Polymorphisms in the Promoter Region of the Sialyltransferase 8B (SIAT8B) Gene and Schizophrenia
|Biological Psychiatry|2005|129